PIRACETAM HELPS RESTORE VISION AFTER CRANIOCEREBRAL TRAUMA

Area of Science:

• Neuroscience
• Ophthalmology
• Pharmacology

Background:

• Traumatic brain injury (TBI) can lead to significant visual impairments.
• Restoring visual function is crucial for patient recovery and quality of life.
• Piracetam is a nootropic drug with potential neuroprotective and neuroplasticity-enhancing properties.

Purpose of the Study:

• To investigate the effects of piracetam on visual functions in patients with traumatic brain injury.
• To assess piracetam's impact on luminance sensitivity threshold (LST) and visual-motor reaction time (VMRT).
• To explore the relationship between injury severity and piracetam's efficacy in visual recovery.

Main Methods:

• A 4-week randomized controlled trial involving 60 patients with TBI, divided into mild TBI, moderate TBI, and placebo groups.
• Assessment of luminance sensitivity threshold (LST) and visual-motor reaction time (VMRT) using color campimetry before and after piracetam treatment.
• Statistical analysis using Student's and sign criteria to evaluate changes in visual parameters.

Main Results:

• Piracetam administration led to improvements in visual functions, including LST and VMRT, in TBI patients.
• The degree of visual recovery appeared to correlate with the severity of the traumatic brain injury.
• Ophthalmoscopic changes associated with craniocerebral trauma showed potential for restoration with piracetam treatment.

Conclusions:

• Piracetam demonstrates potential therapeutic value in improving visual function following traumatic brain injury.
• The drug may contribute to enhanced brain activity and neuroplasticity, aiding visual system recovery.
• Further research is warranted to optimize piracetam dosage and treatment protocols for different TBI severities.